β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease

The relationship between progressive cognitive decline and underlying neuropathology associated with Alzheimer s disease (AD) is a key issue in defining the mechanisms responsible for functional loss. This has been a subject of much controversy, with separate studies comparing various clinical and neuropathological indices in AD. Further, it is difficult to compare studies with differences in histochemical staining protocols, brain regions examined, and data quantification criteria. There are many difficulties in designing a clinical-pathological correlative study involving AD patients. It is necessary to control for several key parameters. For example, a broad range of cognitively impaired subjects is needed, as well as short postmortem delays, brief intervals between cognitive testing and death, and the most sensitive detection and quantification techniques. In this study, we carefully controlled for each of these parameters to determine if there is a relationship between global cognitive dysfunction and multiple neuropathological indices. We selected 20 individuals representing a broad range of cognitive ability from normal to severely impaired based on the MMSE, Blessed IMC, and CDR. We counted plaque number, NFT number, dystrophic neurite number, and the relative extent of thioflavine positive plaques and neuritic involvement within plaques. We also quantified cortical area occupied by beta-amyloid immunoreactivity (A beta Load) and PHF-1 positive neuropil threads and tangles (PHF Load) using computer-based image analysis. Interestingly, we found that most pathologic measures correlated highly with the severity of dementia. However, the strongest predictor of premortem cognitive dysfunction on all three cognitive measures was the relative area of entorhinal cortex occupied by beta-amyloid deposition. In conclusion, our data show that in a carefully controlled correlative study, a variety of neuropathological variables are strongly correlated with cognitive impairment. Plaque related variables may be as strongly related to cognitive dysfunction as other established measures, including synapse loss, cell death and tau hyperphosphorylation, although no correlative study can demonstrate causality.

[1]  I. Kanazawa,et al.  Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease , 1995, Nature Genetics.

[2]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[3]  Anthony F Jorm,et al.  The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms , 1989, Psychological Medicine.

[4]  D. Schubert,et al.  Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Lynch,et al.  Induction of β-Amyloid-Containing Polypeptides in Hippocampus: Evidence for a Concomitant Loss of Synaptic Proteins and Interactions with an Excitotoxin , 1994, Experimental Neurology.

[6]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[7]  C. Duyckaerts,et al.  Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.

[8]  Paul J. Harrison,et al.  Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study , 1994, Neuroscience.

[9]  S. Younkin.  The amyloid beta protein precursor mutations linked to familial Alzheimer's disease alter processing in a way that fosters amyloid deposition. , 1994, The Tohoku journal of experimental medicine.

[10]  Carl W. Cotman,et al.  Color image analysis in neuroanatomical research: Application to senile plaque subtype quantification in Alzheimer's disease , 1995, Neurobiology of Aging.

[11]  E. Masliah,et al.  Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. , 1990, The American journal of pathology.

[12]  C. Cotman,et al.  β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.

[13]  A. Klug,et al.  Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Beyreuther,et al.  Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. , 1993, Dementia.

[15]  W. Schlote,et al.  Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories A European multicenter study under the auspices of EURAGE , 1990, Journal of the Neurological Sciences.

[16]  Brian J Cummings,et al.  β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease , 1994, Neuroscience.

[17]  C. Bieberich,et al.  The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice , 1995, Nature Genetics.

[18]  Peter Davies,et al.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.

[19]  J. Trojanowski,et al.  Alzheimer disease A68 proteins injected into rat brain induce codeposits of beta-amyloid, ubiquitin, and alpha 1-antichymotrypsin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Smith,et al.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. , 1995, Dementia.

[21]  K. Kosik,et al.  Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.

[22]  J. Troncoso,et al.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.

[23]  C. Duyckaerts,et al.  Does amyloid precede paired helical filaments in the senile plaque? A study of 15 cases with graded intellectual status in aging and Alzheimer disease , 1988, Neuroscience Letters.

[24]  Brian J Cummings,et al.  β-Amyloid Accumulation Correlates with Cognitive Dysfunction in the Aged Canine , 1996, Neurobiology of Learning and Memory.

[25]  L. Thal,et al.  Alzheimer's disease , 1986, Neurology.

[26]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[27]  N. Milgram,et al.  Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. , 1994, Behavioral neuroscience.

[28]  S. Prusiner,et al.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[29]  R. Mantegna,et al.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Brian J Cummings,et al.  Constructional apraxia in Alzheimer's disease correlates with neuritic neuropathology in occipital cortex , 1996, Brain Research.

[31]  D. Sparks,et al.  Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. , 1996, Dementia.

[32]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[33]  S. Rapoport,et al.  β-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease , 1994, Brain Research.

[34]  R. McConnell,et al.  Microwave antigen retrieval for immunocytochemistry on formalin‐fixed, paraffin‐embedded post‐mortem CNS tissue , 1995, The Journal of pathology.

[35]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[36]  P. Davies,et al.  A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Hachinski,et al.  A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA , 1985, The Lancet.

[38]  C. Glabe,et al.  Intracellular Aβ1-42 Aggregates Stimulate the Accumulation of Stable, Insoluble Amyloidogenic Fragments of the Amyloid Precursor Protein in Transfected Cells (*) , 1995, The Journal of Biological Chemistry.

[39]  Brian J Cummings,et al.  beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. , 1992, Neuroreport.

[40]  C. Duyckaerts,et al.  COMPARISON OF SEVEN STAINING METHODS FOR SENILE PLAQUES AND NEUROFIBRILLARY TANGLES IN A PROSPECTIVE SERIES OF 15 ELDERLY PATIENTS , 1989, Neuropathology and applied neurobiology.

[41]  L. Lapham,et al.  Clinicopathologic Correlates in Alzheimer Disease: Assessment of Clinical and Pathologic Diagnostic Criteria , 1993, Alzheimer disease and associated disorders.

[42]  L. Iversen,et al.  The toxicity in vitro of beta-amyloid protein. , 1995, The Biochemical journal.

[43]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[44]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[45]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[46]  J. C. Chisholm,et al.  The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. , 1995, Journal of neurobiology.

[47]  Brian J Cummings,et al.  Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in alzheimer's disease , 1992, Neuroscience.

[48]  S. DeKosky,et al.  APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. , 1995, Nature genetics.

[49]  J. Miller,et al.  Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. , 1993, Archives of neurology.

[50]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[51]  K. Jellinger,et al.  Synaptic Pathology of Alzheimer's Disease a , 1993, Annals of the New York Academy of Sciences.

[52]  Brian J Cummings,et al.  The canine as an animal model of human aging and dementia , 1996, Neurobiology of Aging.

[53]  E. Masliah,et al.  A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  D. Sparks,et al.  Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease , 1993, Annals of neurology.

[55]  D. Dickson,et al.  Primitive plaques and memory dysfunction in normal and impaired elderly persons. , 1987, The New England journal of medicine.

[56]  J. Growdon,et al.  Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Alzheimer's Disease ‐ Window on Molecular Epidemiology a , 1996, Annals of the New York Academy of Sciences.

[57]  J. Rostas,et al.  A rapid method for isolation of synaptosomes on Percoll gradients , 1986, Brain Research.

[58]  G. K. Wilcock,et al.  Plaques, tangles and dementia A quantitative study , 1982, Journal of the Neurological Sciences.

[59]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[60]  M. Ilyas Kamboh,et al.  A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism , 1995, Nature Genetics.

[61]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[62]  B. Hyman,et al.  The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimer's Disease Suggests a Dynamic Balance Between Amyloid Deposition and Resolution , 1993, Journal of neuropathology and experimental neurology.

[63]  K. Wisniewski,et al.  Ageing in higher functioning adults with Down's syndrome: an interim report in a longitudinal study. , 2008, Journal of intellectual disability research : JIDR.

[64]  Paul D. Coleman,et al.  Neuron numbers and dendritic extent in normal aging and Alzheimer's disease , 1987, Neurobiology of Aging.

[65]  N. Akaike,et al.  Amyloid β protein‐induced irreversible current in rat cortical neurones , 1994 .

[66]  W. Müller,et al.  beta-Amyloid peptide decreases membrane fluidity. , 1995, Brain research.

[67]  Jacob Cohen,et al.  Applied multiple regression/correlation analysis for the behavioral sciences , 1979 .

[68]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[69]  Brian J Cummings,et al.  Spatial learning and memory as a function of age in the dog. , 1995, Behavioral neuroscience.

[70]  J. Hauw,et al.  Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease , 1995, Neurobiology of Aging.

[71]  D. Salmon,et al.  Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations , 1991 .

[72]  Brian J Cummings,et al.  Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. , 1994, Neuroscience.

[73]  L Carlin,et al.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. , 1995, Archives of neurology.

[74]  H. Soininen,et al.  Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease , 1995, Neuroscience.

[75]  W. Müller,et al.  β-amyloid peptide decreases membrane fluidity , 1995, Brain Research.

[76]  W. Honer,et al.  Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.

[77]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Brian J Cummings,et al.  Subpopulations of dystrophic neurites [correction of neuritis] in Alzheimer's brain with distinct immunocytochemical and argentophilic characteristics. , 1994, Brain research.

[79]  B. Crain,et al.  Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Journal of neuropathology and experimental neurology.

[80]  H. Wiśniewski,et al.  Alzheimer’s Disease, a Cerebral Form of Amyloidosis , 1988 .

[81]  B. Yankner,et al.  β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.

[82]  D. Selkoe,et al.  Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.

[83]  Brian J Cummings,et al.  Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity , 1995, The Lancet.

[84]  D. Troost,et al.  Tissue fixation methods alter the immunohistochemical demonstrability of neurofilament proteins, synaptophysin, and glial fibrillary acidic protein in human cerebellum. , 1993, Acta histochemica.

[85]  Brian J Cummings,et al.  β-Amyloid accumulation in aged canine brain: A model of early plaque formation in Alzheimer's disease , 1993, Neurobiology of Aging.

[86]  C. Cotman,et al.  Senile plaques as aberrant sprout-stimulating structures , 1986, Experimental Neurology.

[87]  J. Wegiel,et al.  Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines * , 1996, Neuropathology and applied neurobiology.

[88]  H. Wiśniewski,et al.  AGE-ASSOCIATED DEVELOPMENT OF DIFFUSE AND THIOFLAVINE-S-POSITIVE PLAQUES IN DOWN SYNDROME , 1994 .

[89]  C. Duyckaerts,et al.  Alzheimer's lesions labelled by anti‐ubiquitin antibodies: comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease , 1993, Neuropathology and applied neurobiology.

[90]  N. Akaike,et al.  Flow cytometric analysis on cytotoxic action of amyloid β protein fragment 25–35 on brain neurons dissociated from the rats , 1994, Brain Research.

[91]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[92]  P. Yates,et al.  THE TOPOGRAPHY OF PLAQUES AND TANGLES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES , 1986, Neuropathology and applied neurobiology.

[93]  M. Mattson,et al.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.